ISSN: 0973-7510

E-ISSN: 2581-690X

Review Article | Open Access
Shweta Srivastava, Neha Shree Maurya, Shikha Kushwah and Ashutosh Mani
Department of Biotechnology, Motilal Nehru National Institute of Technology Allahabad, Prayagraj – 211 004, India.
J Pure Appl Microbiol. 2021;15(2):484-499 | Article Number: 6667 | © The Author(s). 2021
Received: 22/09/2020 | Accepted: 25/03/2021 | Published: 19/04/2021

Aspergillosis is a fungal disease caused by different species of Aspergillus. They live in soil,dust and decomposed material. Number of Aspergillus species found till now is about 300 and more are still to be identified. Only few Aspergillus species can cause human disease and the most common species for human infection is Aspergillus fumigatus, which is a ubiquitous airborne saprophytic fungus. Severity of the disease ranges from an allergic response to life-threatening generalized infection. They grow optimally at 37°C and can grow upto 50°C. The fungal conidia are being constantly inhaled by humans and animals everyday normally gets eliminated by innate immune mechanism. Due to increasing number of immunocompromised patients, severe and fatal Aspergillosis cases  have augmented. Currently, available antifungal drug for the treatment of  Aspergillosis act on these three molecular  target are 14 alpha demethylase for Azoles, ergosterol for Polyene and β-1,3-glucan synthase for Echinocandin. These antifungal drug show high resistance problem and toxicity. So, it is high time to develop new drugs for treatment  with reduced toxicity and drug resistant problem. Synthesis of essential amino acid is absent in human as they obtain it from their diet but fungi synthesis these amino acid. Thus, enzymes in this pathway acts as novel drug target. This article summarizes promising drug targets  presents in different metabolic pathway of Aspergillus genome and discusses their molecular functions in detail. This review also list down the inhibitors  of these  novel target. We present a comprehensive review that will pave way for discovery and development of novel antifungals against these drug targets for Aspergillosis treatment.


Aspergillosis, Novel Targets, Aspergillus fumigatus, Antifungal, Pathways, Enzymes, Fungi, Inhibitors

Article Metrics

Article View: 32

Share This Article

© The Author(s) 2021. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.